Wells Fargo analyst Stephen Baxter raised the firm’s price target on McKesson (MCK) to $766 from $691 and keeps an Equal Weight rating on the shares. The firm is updating its model following Q4 earnings and fiscal 2026 guide. Wells remains on the sidelines given premium vs. peers required despite what it sees as more exposure to overhangs.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK:
- McKesson Issues $2 Billion Notes for Acquisition
- Sector Spotlight: Trump executive order targets drug prices
- McKesson’s Strategic Positioning and Growth Potential: Buy Rating with $800 Price Objective
- Strategic Spin-Off and Strong Core Businesses Drive McKesson’s Buy Rating
- Trump’s drug-price crackdown may lead to minor concessions, WSJ reports